Harmony Biosciences Holdings, Inc.
—- Market cap
- —
- Debt
- +$163.66M
- Cash
- −$775.34M
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: HRMY stock price vs JXN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at JXN's multiple
Needs JXN P/E.
Implied fair value · at HRMY's multiple
Needs EPS (TTM) is negative, HRMY P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: HRMY FY 2025 (ended Dec 31, 2025) · JXN FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
HARMONY BIOSCIENCES HOLDINGS, INC. · implied price per share
Bear
$42.25
Base
$49.71
Bull
$57.16
Jackson Financial Inc. · implied price per share
Bear
$15.41
Base
$18.13
Bull
$20.85
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.19x
0.30x
Net debt / EBITDA
Leverage against operating earnings
-2.20x
-14.62x
Cash and equivalents
Liquid reserves on the balance sheet
$775.34M
$5.70B
Total debt
Interest-bearing obligations outstanding
$163.66M
$3.00B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Jazz Pharmaceuticals plc
HRMY vs JAZZ
SUPERNUS PHARMACEUTICALS, INC.
HRMY vs SUPN
Intra-Cellular Therapies, Inc.
HRMY vs ITCI
ACADIA PHARMACEUTICALS INC
HRMY vs ACAD
Vanda Pharmaceuticals Inc.
HRMY vs VNDA
LivaNova PLC
HRMY vs LIVN
PRUDENTIAL FINANCIAL INC
HRMY vs PRU
HARTFORD FINANCIAL SERVICES GROUP, INC.
HRMY vs HIG
METLIFE INC
HRMY vs MET
LINCOLN NATIONAL CORP
HRMY vs LNC
Brighthouse Financial, Inc.
HRMY vs BHF
GLOBE LIFE INC.
HRMY vs GL
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
Live quote